Did our lack of domestic manufacturing capacity for a virus-based platform vaccine lead to a higher premium with the AstraZeneca vaccine?
On April 16th, 2021. See this statement in context.
On April 16th, 2021. See this statement in context.
Conservative
Michelle Rempel Conservative Calgary Nose Hill, AB
Did our lack of domestic manufacturing capacity for a virus-based platform vaccine lead to a higher premium with the AstraZeneca vaccine?
See context to find out what was said next.